Document Detail


Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
MedLine Citation:
PMID:  19728162     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Lynch syndrome is an inherited cancer syndrome caused by germline mutations in mismatch repair (MMR) genes MLH1, MSH2, MSH6 and PMS2. LS predisposes to high risk of early-onset colorectal, endometrial and other tumors. Patients with Lynch syndrome have also been shown to have an elevated risk for pancreatic cancer (PC). In this study, we aimed to estimate the frequency of suspected Lynch syndrome among a series of 135 PC patients. Further, we wanted to determine the frequency of MMR gene mutations in the suspected Lynch syndrome cases. We also aimed to verify the pathogenicity of any novel non-truncating variants we might detect with a functional assay. Based on personal and/or familial cancer history, 19 patients were classified as suspected Lynch syndrome cases. DNA material for mutation analysis was available for eleven of them. Four patients were found to carry a total of five MLH1 or MSH2 variants. Of these, MSH2-Q402X, MSH2-G322D, and MLH1-K618A had been previously reported, while the MSH2-E205Q and MSH2-V367I variants were novel. MSH2-Q402X is a known stop mutation and reported here for the first time here in association with PC. MLH1-K618A was found in the unaffected branch of a kindred, suggesting that it may be a polymorphism or a low penetrance variant. MSH2-G322D likely does not cause a MMR defect, although this variant has also been associated with breast cancer as indeed seen in our patient. The novel variants MSH2-E205Q and MSH2-V367I were found in the same patient. Both novel variants were however functional in the applied MMR assay. Our findings suggest that only a small subset of pancreatic cancer patients carry pathogenic MMR mutations.
Authors:
S Gargiulo; M Torrini; S Ollila; S Nasti; L Pastorino; R Cusano; L Bonelli; L Battistuzzi; L Mastracci; W Bruno; V Savarino; S Sciallero; G Borgonovo; M Nyström; G Bianchi-Scarrà; C Mareni; P Ghiorzo
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Familial cancer     Volume:  8     ISSN:  1573-7292     ISO Abbreviation:  Fam. Cancer     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-04     Completed Date:  2010-01-08     Revised Date:  2011-11-24    
Medline Journal Info:
Nlm Unique ID:  100898211     Medline TA:  Fam Cancer     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  547-53     Citation Subset:  IM    
Affiliation:
Department of Oncology, Biology and Genetics, University of Genoa, 16132 Genoa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adaptor Proteins, Signal Transducing / genetics*
Adult
Base Sequence
Colorectal Neoplasms, Hereditary Nonpolyposis / complications,  genetics*
DNA Mismatch Repair / genetics
DNA Mutational Analysis
Female
Genetic Predisposition to Disease*
Germ-Line Mutation
Humans
Immunohistochemistry
Italy
Male
Microsatellite Instability
Middle Aged
MutS Homolog 2 Protein / genetics*
Nuclear Proteins / genetics*
Pancreatic Neoplasms / genetics*
Pedigree
Reverse Transcriptase Polymerase Chain Reaction
Grant Support
ID/Acronym/Agency:
GTB07001//Telethon
Chemical
Reg. No./Substance:
0/Adaptor Proteins, Signal Transducing; 0/MLH1 protein, human; 0/Nuclear Proteins; EC 3.6.1.3/MSH2 protein, human; EC 3.6.1.3/MutS Homolog 2 Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin.
Next Document:  Teaching virtue: pedagogical implications of moral psychology.